Canesten is a licensed medicine, so it cannot answer thrush misinformation on TikTok and Instagram in its own words the way the misinformation is spread.
The problem is documented by somebody with nothing to gain from the agency winning the work.
How we know
The published scope for Canesten is social content aimed at women aged 18 to 30, a campaign to counter misinformation about thrush, influencer activity and experiential work. That a regulated medicine brand cannot post freely is a matter of UK advertising law.
| Who says so | PRWeek UK, with The Go Network's agency moves roundup logging it independently. Read it |
|---|---|
| A second source | The Go Network's February 2026 UK agency moves roundup states independently that Bayer appointed W Communications as the PR agency for its consumer health brands Canesten and Berocca in the UK, and classes the win under healthcare and consumer health. |
| What the agency was asked to do | Not published as a quoted brief. On record: W leads social content for Canesten targeting women aged 18 to 30, and will develop a campaign to address misinformation around thrush, plus influencer activity and experiential campaigns. The account also covers Berocca. |
| How that happened | PRWeek UK reports the appointment but does not say whether there was a pitch or who else was considered. W Communications announced it on its own LinkedIn the same day. |
| How long it took | Announced 6 February 2026. Pitch length, start date and contract length not published. |
| Recorded as | Bayer UK (Canesten, Berocca) (Bayer Consumer Health) |
Every other case where there were rules about what they could say →
← Every caseEvery case here carries the one link that proves it, and names who said it. Where that is the agency describing its own win, the card says so rather than hiding it. Cases where nobody ever documented a reason are not on this page at all. Brought to you by Influencer Advisory, your influencer marketing partner for supplement, health and beverage brands.